Table IV.
Independent and joint contributions of in utero and current secondhand smoke exposure on asthma control.
| In utero | Current | GALA II + SAGE II | GALA II (Latino) | SAGE II (Black) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | Odds ratio | P Value | N | Odds ratio | P Value | N | Odds ratio | P Value | ||
| No | No | 1805 | 1.0 | 1422 | 1.0 | 383 | 1.0 | |||
| Yes | No | 113 | 1.8 (1.2–2.8) | 0.008 | 44 | 2.0 (1.0–4.0) | 0.04 | 69 | 1.5 (0.8–2.7) | 0.17 |
| No | Yes | 464 | 1.1 (0.9–1.4) | 0.25 | 320 | 1.2 (0.9–1.6) | 0.28 | 114 | 1.1 (0.7–1.7) | 0.62 |
| Yes | Yes | 106 | 1.3 (0.8–2.0) | 0.24 | 58 | 1.8 (0.9–3.2) | 0.06 | 48 | 0.8 (0.4–1.6) | 0.45 |
Odds ratios adjusted for eczema status; use of asthma control medication; log-transformed serum IgE; father’s employment status; annual income; presence of mold or cockroaches in home; SHS exposure during first 2 years of life; race/ethnicity; age; gender; and study center.